Skip to main content
CRL logo

CRL · Charles River Laboratories International, Inc. · Analyst Estimates

Track CRL — free
$295.01 -0.95 (-0.32%) At close · Sep 30
Market Cap
$14.20B
Shares
47.74M
Volume · Sep 30 799.36K Avg daily vol (3M) 922.66K

Analyst Estimates

Compare analyst forecasts for Charles River Laboratories International, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-01 04:35 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
11.02
11.3487
11.49297
—
11.31818
11.10434
11.33064
11.09282
— — — —
EPS
analysts
Publication date not stated
— — —
17
— — — —
1
1
12
1
Revenue
USD
Publication date not stated
3901100000
3918289240
3958100000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
10
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
11.7
12.73694
13.67614
—
12.68598
12.33015
12.71092
12.3169
— — — —
EPS
analysts
Publication date not stated
— — —
17
— — — —
1
1
13
0
Revenue
USD
Publication date not stated
3933800000
4006193920
4072340000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
2.92
2.96447
3.08858
—
2.95183
3.05475
2.95084
3.04459
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
9
0
1
1
Revenue
USD
Publication date not stated
951297340
959825540
984200000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
10
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
3.0
3.31749
3.46
—
3.3141
3.22786
3.30876
3.2356
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
1
0
9
1
Revenue
USD
Publication date not stated
943000000
955505010
974100000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
10
— — — — — — — —
Key facts CIK 1100682 CUSIP 159864107 13F (30d) 14 filings 12 filers Visit website Investor relations